Eastgate Biotech Announces That it Has Received a Substantial Order for Glucora, Its Natural Glucose Management Product
05 mai 2016 08h00 HE
|
EastGate Pharmaceuticals Inc
West Caldwell, NJ and Toronto, Canada, May 05, 2016 (GLOBE NEWSWIRE) -- West Caldwell, NJ and Toronto, May 2, 2016 (GlobeNewswire/-) EastGate Biotech Corp. (PinkSheets: ETBI), an emerging...
InSpark Technologies Enters into Clinical Trial Collaborations to Study the Effectiveness of Mobile Health Technology in Preventing Low Blood Sugars in People With Diabetes
05 mai 2016 08h00 HE
|
InSpark Technologies
CHARLOTTESVILLE, Va., May 05, 2016 (GLOBE NEWSWIRE) -- InSpark Technologies, Inc. announced today that it has entered into clinical study collaborations with Atlanta Diabetes Associates, a large...
WellDoc® Announces Spring/Summer 2016 Conference Schedule
04 mai 2016 11h45 HE
|
WellDoc Inc.
BALTIMORE, May 04, 2016 (GLOBE NEWSWIRE) -- WellDoc, a digital health technology leader, today announced its planned participation at several upcoming conferences and industry events in the coming...
Eastgate Biotech Announces That it Has Received a Substantial Order for Glucora, Its Natural Glucose Management Product
03 mai 2016 08h00 HE
|
EastGate Pharmaceuticals Inc
West Caldwell, NJ and Toronto, Canada, May 03, 2016 (GLOBE NEWSWIRE) -- West Caldwell, NJ and Toronto, May 2, 2016 (GlobeNewswire/-) EastGate Biotech Corp. (PinkSheets: ETBI), an emerging...
Eastgate Biotech Announces That it Has Received a Substantial Order for Glucora, Its Natural Glucose Management Product
02 mai 2016 08h00 HE
|
EastGate Pharmaceuticals Inc
West Caldwell, NJ and Toronto, Canada, May 02, 2016 (GLOBE NEWSWIRE) -- West Caldwell, NJ and Toronto, May 2, 2016 (GlobeNewswire/-) EastGate Biotech Corp. (PinkSheets: ETBI), an emerging...
Sinocare Enters Into Definitive Agreement to Acquire PTS Diagnostics
02 mai 2016 05h00 HE
|
Sinocare Inc.
CHANGSHA, China, May 02, 2016 (GLOBE NEWSWIRE) -- Sinocare Inc. (San Nuo Sheng Wu) (SHE:300298), announced today it has signed a definitive purchase agreement with privately-held PTS Diagnostics,...
Integra LifeSciences Provides Update for Omnigraft™ Commercialization Plans, Including Expectations for an Earlier Launch
27 avr. 2016 06h00 HE
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., April 27, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company is...
New Vigilant™ Diabetes Management Companion Launched in U.S. That Alerts Users to Risk of Severe Hypoglycemia in Next 24 Hours
26 avr. 2016 08h00 HE
|
InSpark Technologies
CHARLOTTESVILLE, Va., April 26, 2016 (GLOBE NEWSWIRE) -- InSpark Technologies, Inc., a leader in diabetes pattern recognition technology, today announced that VigilantTM1 is now available for...
Early mHealth Adopters Want to Prevent, Control Chronic Conditions
11 avr. 2016 08h04 HE
|
KantarHealth
NEW YORK, April 11, 2016 (GLOBE NEWSWIRE) -- While mHealth technologies are gaining popularity for tracking general health, many consumers are using mHealth devices to actively try to lower their...
Helmsley Charitable Trust Awards $2.1 Million to Penn, Stanford and Seattle Children's Research Institute to Explore Cell-Based Therapies for Type 1 Diabetes
07 avr. 2016 09h05 HE
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, April 7, 2016 (GLOBE NEWSWIRE) -- The Type 1 Diabetes (T1D) Program of The Leona M. and Harry B. Helmsley Charitable Trust has announced $2.1 million in grants to support research toward the...